Accessibility Menu
 

The Best of 2012 #7: Sunesis

After announcing an expansion of P3 trials for its acute myeloid leukemia drug, Sunesis Pharmaceuticals shot to new heights, up 325% for the year. That puts it at #7 on our list of the very best stocks in healthcare for 2012.

By Dave Williamson and Max Macaluso Dec 13, 2012 at 5:24PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.